Sierra Leone: TB Bacteria Resistant to Drugs
Programme manager of the National Leprosy and Tuberculosis Control Program (NLTCP) in the ministry of health and sanitation has confirmed that the mycobacterium bacteria that causes tuberculosis (TB) has put on a resistance against the Rifampin and Isoniazid drugs they have been administering to TB patients over the years, due to some patients’ failure to take the drugs regularly.
Dr. Alie H. Wurie said the development was detected this year globally, noting thatthe mycobacterium bacteria has put on resistance to some TB patients who fail to take the drugs on a regular basis, despite the drugs being prescribed by the World Health Organization (WHO) for the treatment of TB globally.
He said they are now looking for ways to overcome the resistance of the bacteria as it has become a global concern; and at the same time encouraging TB patients to regularly take their drugs to avoid them being resisted by the bacteria. “Not all patients are experiencing this problem; those who take the drugs the right way have no problem. It is a concern that we are going to properly address,” said Dr. Wurie.
According to him, the main cause of TB is mycobacterium tuberculosis – a small, aerobic, nonmotile bacillus. The high lipid content of this pathogen accounts for many of its unique clinical characteristics, he added.
Dr.Wuriewas speaking to Concord Times in an exclusive interview yesterday at his New England Ville office in Freetown.